Zhen Li
Patrimonio netto: 117 M $ in data 30/09/2026
Patrimonio netto: 117 M $ in data 30/09/2026
Dr. Zhen Li is a President, Chief Executive Officer & Director at ADARx Pharmaceuticals, Inc. She is on the Board of Directors at ADARx Pharmaceuticals, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/09/2026 | 5.861.199 ( 5,49% ) | 117 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Fondatore | 01/12/2019 |
| Società | Posizione | Fine |
|---|---|---|
| MERCK & CO., INC. | Direttore/Membro del Consiglio | - |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale